As PPAR modulation regulates ocular and uterine angiogenesis, it is of great importance to investigate the effects on angiogenesis in therapeutic interventions using PPAR regulators against diabetic retinopathy or endometriosis, as both pathologies depend on an excessive vascularization [160,161], which is also the case in rheumatoid arthritis [162]. Here, PPARA is linked to diabetic retinopathy.